awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33377668-EFE5BD67-9FC0-455E-A82A-4C94A22B8CEE
Q33377668-EFE5BD67-9FC0-455E-A82A-4C94A22B8CEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33377668-EFE5BD67-9FC0-455E-A82A-4C94A22B8CEE
A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors
P2860
Q33377668-EFE5BD67-9FC0-455E-A82A-4C94A22B8CEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33377668-EFE5BD67-9FC0-455E-A82A-4C94A22B8CEE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2b803dabd2861832dbb312e97c833289102799bf
P2860
Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer.